Skip to main content
Figure 1 | Trials

Figure 1

From: Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction (EXAMI): study protocol for a randomized controlled trial

Figure 1

Flowchart of the study design. This figure illustrates the study design. A total of 108 patients will be randomized to Exenatide (n = 54) or placebo (n = 54) infusion. The treatment will be initiated just prior to PCI and will be continued for 72 hours. Echocardiography and MRI will be performed during hospital admission (within 2-7 days for echo and within 3-7 days for MRI) and at 4 months follow up.

Back to article page